首页 › 基金 › KVP Capital Advisors, LP › DARE

KVP Capital Advisors, LP 对 DARE 的持仓历史

YARROW BIOSCIENCE INC · 医疗保健

KVP Capital Advisors, LP 在 Q3 2026 的 13F 申报中披露持有 DARE(YARROW BIOSCIENCE INC)10,011 股,市值约 US$225K,约占其申报组合的 0.18%,在其申报持仓中市值排名第 35 位。 KVP Capital Advisors, LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)10.01K 股
申报持仓市值$225.45K
组合权重0.18%
首次申报Q3 2026
最近变动新进
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

KVP Capital Advisors, LP 对 DARE 的持仓演变

KVP Capital Advisors, LP 于 Q3 2026 首次披露 DARE 持仓:10,011 股(约 US$225K)。

逐季持仓明细

季度股数金额变化
Q3 2026 10.01K $225.45K 新进

关于 DARE 与 13F 数据

DARE(YARROW BIOSCIENCE INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 DARE,申报仓位最大的包括:Logos Global Management LP (US$23.1M), Spruce Street Capital LP (US$13.7M), SILVERARC CAPITAL MANAGEMENT, LLC (US$6.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 DARE 的基金

查看 DARE 的全部基金持有人 →

常见问题

How long has KVP Capital Advisors, LP held DARE?

KVP Capital Advisors, LP has disclosed DARE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is KVP Capital Advisors, LP's current position in DARE?

As of Q3 2026, KVP Capital Advisors, LP holds 10.01K shares of DARE (YARROW BIOSCIENCE INC), valued at $225.45K, representing 0.18% of its reported portfolio and ranking #35.

Has KVP Capital Advisors, LP been buying or selling DARE?

In the latest 13F filing (Q3 2026), KVP Capital Advisors, LP newly opened its position in DARE.

Which other funds hold DARE?

Other major institutional holders of DARE include Logos Global Management LP, Spruce Street Capital LP, SILVERARC CAPITAL MANAGEMENT, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.